RADLogics’ AI-Powered Applications Available on Nuance AI Marketplace

RADLogics recently announced that its AI-Powered medical imaging applications designed to assist in the detection and quantification of findings associated with COVID-19 will be available on the Nuance AI Marketplace. The Nuance AI Marketplace is a portal with...

AHRA Announces Election Results

AHRA’s online Board of Directors election closed at midnight on May 18, 2020. The newest members of the AHRA Board of Directors are: 2020-2021 President-Elect: Kimlyn Queen-Weis, CRA, FAHRA Kimlyn joined AHRA in 2004, earned her CRA in 2004, and achieved Fellow...

United Imaging Wins Multiple Stevie Awards

United Imaging was named the winner of five Stevie Awards in the 18th Annual American Business Awards, including a Gold Award for “Most Innovative Company of the Year – Up to 2,500 Employees” for its U.S.-based operations, which were established in 2018. United...

Life Image Launches Patient Connect Portal

Life Image, a global medical evidence network specializing in curating diagnostic images for care delivery and research, has announced the launch of its Patient Connect Portal. The platform gives patients control over their own images and medical data to help manage...

Surgeries Power C-arm Market Growth

A C-arm is a medical imaging tool with a C-shaped arm that attaches the X-ray source and X-ray detector to each other. These devices offer high-resolution X-ray images in real-time, thereby permitting medical professionals to observe progress at any point during the operation and promptly make required alterations.

The growth of innovative C-arms has broadened their application area, adding considerably to the growth of the global fluoroscopy and mobile C-arms market, according to Market Data Forecast.

In the present world, imaging systems are a vital technology in every hospital. Experts in fields such as surgery, orthopedics, neurology, urology and cardiology utilize C-arms for intraoperative imaging.

The North America C-arm market was worth $1.4 billion in 2018 and estimated to be growing at a compound annual growth rate (CAGR) of 3.78 percent, to reach $1.68 billion by 2023, according to Market Data Forecast.

The growth of the North America C-arm market is mainly due to factors such as rising awareness regarding interventional surgeries, increasing implementation of minimally intrusive surgeries, growing demand for superior imaging technology and for C–Arms in cardiology and vascular surgery, according to Market Data Forecast.

The research group also suggests that an increasing emphasis on the transportability of C-arms has created a market opportunity for companies manufacturing mini C-arms. However, factors such as growing utilization of refurbished devices, increasing cost concerns and the low substitution rates of C-arm systems are obstructing the growth of the market in this region, according to Market Data Forecast.

In 2015, North America led the global C-arm market in terms of both value and capacity, according to Market Data Forecast.

“The market in this region is projected to grow strongly during the forecast period due to various factors such as growing awareness about medical imaging tools, financial strength to procure expensive devices and adoption of advanced products,” according to Market Data Forecast. “The market is highly consolidated due to the high prices of equipment and a huge amount of capital is required for the entry of a new company into the market. This has led to a formidable competition among prominent market players. The major companies dominating the C-Arms market in this region are GE Healthcare Inc., Varian Medical Systems Inc., Philips Healthcare, Siemens AG, Toshiba Corp., Hologic corp., Omega Medical Imaging Inc., BMI Biomedical International, Hitachi Ltd., DMS Health Technologies, ATON GmbH, Medonica Co Ltd., Gemss Co Ltd. and Shimadzu Corp.”

The growing importance of medical imaging in the global health care industry is helping to boost the market for fluoroscopes and C-arms, according to a report by BCC Research. fluoroscopes and C-arms are medical imaging systems that are based on X-ray technology that can produce real-time dynamic images.

The global market is estimated to be worth $2.7 billion in 2022, reaching a CAGR of 3.8 percent, according to the report “Fluoroscopy and C-arms: Technologies and Global Markets.”

The market for cardiovascular applications is driven mainly by the growing number of interventional heart procedures, especially minimally invasive surgeries. The increasing dependence on advanced mobile C-arms for these cardiovascular applications has caused a positive impact on the market.

Major players within this market, according to BCC Research, include GE Healthcare, Philips Healthcare, Siemens Healthineers, Shimadzu Scientific Instruments Inc., Toshiba Medical Systems Corp. and Ziehm Imaging Inc.

A separate report also predicts sustained growth in the C-arm market.

A July 2018 report on the future of the C-arm market by Market Research Engine forecasts continued growth. It also includes a detailed study of global and regional markets within the global C-arm market and provides reasons for variations in the growth of the industry in certain regions.

The global C-arm market is expected to exceed more than $3.46 billion by 2022 at a CAGR of 3.82 percent in the given forecast period, according to the Market Research Engine report.

The increasing adoption of mobile C-arms in hybrid ORs is expected to drive the growth of the global market, according to Research and Markets.

“The latest mobile C-arms feature 3D navigation aid and image processing software to improve quality and system capabilities. The analysts have predicted that the surgical imaging devices market will register a CAGR of more than 4 percent by 2022,” according to Research and Markets.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing adoption of mobile C-arms in hybrid ORs.”

According to the report, one of the major drivers for this market is the increase in the prevalence of chronic diseases. Further, the report states that one of the major factors hindering the growth of this market is the high costs of surgical imaging devices. ICE



Submit a Comment

Your email address will not be published. Required fields are marked *